Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sager

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
JACC. Basic to Translational Science|April 22, 2026
Exercise Reverses Mental Stress-Induced Vascular Inflammation and Builds Stress ResilienceUlrike Meyer-Lindemann, Karina Borbil, Marius Schwab, et al.
The Journal of Experimental Medicine|January 18, 2018
Cardiac macrophages promote diastolic dysfunctionMaarten Hulsmans, Hendrik B Sager, Jason D Roh, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
The Canadian Journal of Cardiology|February 4, 2026
Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vesselsAlp Aytekin, Felix Voll, Fiorenzo Simonetti, et al.
JAMA Network Open|December 2, 2024
Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine CareNils Krüger, Johannes Krefting, Thorsten Kessler, et al.
Circulation|October 29, 2020
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionAlp Aytekin, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trialMichael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
JACC. Basic to Translational Science|April 22, 2026
Exercise Reverses Mental Stress-Induced Vascular Inflammation and Builds Stress ResilienceUlrike Meyer-Lindemann, Karina Borbil, Marius Schwab, et al.
The Journal of Experimental Medicine|January 18, 2018
Cardiac macrophages promote diastolic dysfunctionMaarten Hulsmans, Hendrik B Sager, Jason D Roh, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
The Canadian Journal of Cardiology|February 4, 2026
Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vesselsAlp Aytekin, Felix Voll, Fiorenzo Simonetti, et al.
JAMA Network Open|December 2, 2024
Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine CareNils Krüger, Johannes Krefting, Thorsten Kessler, et al.
Circulation|October 29, 2020
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionAlp Aytekin, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trialMichael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.
Pageof 13